Boehringer Ingelheim is a German pharmaceutical company headquartered in Ingelheim am Rhein, Germany. It was founded in 1885 by Albert Boehringer and is still a family-owned company to this day. The company's headquarters are located in Ingelheim, which houses the administration, research and development facilities, as well as production sites.

Boehringer Ingelheim operates in several therapeutic areas including respiratory, cardiovascular, metabolic, immunology, oncology, and central nervous system disorders. They produce both prescription medicines and over-the-counter products. Boehringer Ingelheim has a global presence, with subsidiaries and production plants in over 150 countries worldwide.

The company has formed several noteworthy partnerships and joint ventures. One significant partnership is with Eli Lilly and Company, with whom they collaborate on the development and marketing of diabetes medications. Another joint venture is with Sanofi, called Sanofi Pasteur MSD, which focuses on vaccines for infectious diseases.

In terms of market position, Boehringer Ingelheim is one of the world's top 20 pharmaceutical companies. Its global sales reached €19. 1 billion in 2020, making it one of the largest pharmaceutical companies in Europe.

It faces stiff competition from other multinational pharmaceutical companies such as Pfizer, Novartis, and Johnson & Johnson. Over the years, Boehringer Ingelheim has achieved several milestones and made significant changes to its product lineup. In recent years, the company has focused on the development of drugs for cancer, respiratory diseases, and diabetes.

Notably, in 2018, Boehringer Ingelheim acquired the oncology business of Sanofi, strengthening its presence in the field of cancer research and treatment. Currently, Boehringer Ingelheim is actively involved in researching and developing treatments for COVID-19. The company is collaborating with others in the industry to find effective solutions to combat the global pandemic.

In conclusion, Boehringer Ingelheim is a renowned German pharmaceutical company with a long history and a strong global presence. With a wide range of products and partnerships, it continues to be a major player in the pharmaceutical industry, constantly striving to improve healthcare worldwide